Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
11.43
-0.17 (-1.51%)
Mar 3, 2026, 12:43 PM EST - Market open

COEP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
651127302,494338
Market Cap Growth
84.72%-57.71%-10.53%-98.80%637.84%-
Enterprise Value
611226262,497-
Last Close Price
11.605.5015.6830.63200.00203.80
PS Ratio
131.52---33258.2310990.00
PB Ratio
5.772.9232.856.711061.15-65.73
P/TBV Ratio
7.204.2832.856.711061.15-
EV/Sales Ratio
121.44---33296.44-
Debt / Equity Ratio
0.030.361.500.461.74-0.41
Net Debt / Equity Ratio
-0.460.22-0.30-0.390.81-0.37
Net Debt / EBITDA Ratio
0.42-0.100.010.05-0.14-0.29
Net Debt / FCF Ratio
0.61-0.130.030.45-0.42-0.60
Asset Turnover
0.04---0.020.03
Quick Ratio
2.000.120.511.750.790.04
Current Ratio
2.210.230.591.810.790.04
Return on Equity (ROE)
-171.91%-464.73%-807.49%-1104.48%--
Return on Assets (ROA)
-71.41%-93.24%-215.14%-291.15%-248.47%-451.53%
Return on Capital Employed (ROCE)
-115.20%-228.80%-1358.10%-595.40%-351.10%134.80%
Earnings Yield
-18.80%-86.79%-79.54%-125.73%-0.54%-2.71%
FCF Yield
-12.68%-58.80%-27.08%-12.97%-0.18%-0.93%
Buyback Yield / Dilution
82.00%-49.84%-79.70%-30.98%-79.11%-18.53%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q